Engineers Gate Manager’s Teva Pharmaceuticals TEVA Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$592K Sell
35,340
-70,355
-67% -$1.18M 0.01% 1404
2025
Q1
$1.62M Buy
+105,695
New +$1.62M 0.03% 795
2024
Q4
Sell
-50,157
Closed -$904K 2569
2024
Q3
$904K Buy
50,157
+26,015
+108% +$469K 0.02% 1058
2024
Q2
$392K Sell
24,142
-35,627
-60% -$579K 0.01% 1330
2024
Q1
$843K Sell
59,769
-29,693
-33% -$419K 0.02% 925
2023
Q4
$934K Buy
89,462
+63,140
+240% +$659K 0.03% 833
2023
Q3
$268K Sell
26,322
-53,034
-67% -$541K 0.01% 1369
2023
Q2
$598K Buy
79,356
+22,457
+39% +$169K 0.02% 950
2023
Q1
$504K Sell
56,899
-17,126
-23% -$152K 0.02% 971
2022
Q4
$675K Buy
74,025
+59,220
+400% +$540K 0.04% 723
2022
Q3
$119K Sell
14,805
-17,295
-54% -$139K 0.01% 1422
2022
Q2
$241K Buy
+32,100
New +$241K 0.01% 1549
2022
Q1
Sell
-67,000
Closed -$537K 2303
2021
Q4
$537K Buy
67,000
+56,600
+544% +$454K 0.02% 1000
2021
Q3
$101K Buy
+10,400
New +$101K 0.01% 1531
2021
Q2
Sell
-27,960
Closed -$323K 2009
2021
Q1
$323K Buy
27,960
+10,960
+64% +$127K 0.02% 1275
2020
Q4
$164K Sell
17,000
-17,900
-51% -$173K 0.01% 1521
2020
Q3
$314K Sell
34,900
-39,073
-53% -$352K 0.01% 1223
2020
Q2
$912K Buy
73,973
+30,236
+69% +$373K 0.05% 641
2020
Q1
$393K Sell
43,737
-14,263
-25% -$128K 0.03% 908
2019
Q4
$568K Buy
58,000
+42,900
+284% +$420K 0.03% 930
2019
Q3
$104K Buy
15,100
+3,500
+30% +$24.1K 0.01% 1306
2019
Q2
$107K Buy
+11,600
New +$107K 0.01% 1054